- Home
- PMCB vs ABVC Comparison
PMCB vs ABVC Comparison
Compare PMCB & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- ABVC
- Stock Information
- Founded
- PMCB 1996
- ABVC 2015
- Country
- PMCB United States
- ABVC United States
- Employees
- PMCB N/A
- ABVC N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- PMCB Health Care
- ABVC Health Care
- Exchange
- PMCB Nasdaq
- ABVC Nasdaq
- Market Cap
- PMCB 11.4M
- ABVC 15.1M
- IPO Year
- PMCB N/A
- ABVC N/A
- Fundamental
- Price
- PMCB $1.78
- ABVC $0.64
- Analyst Decision
- PMCB
- ABVC
- Analyst Count
- PMCB 0
- ABVC 0
- Target Price
- PMCB N/A
- ABVC N/A
- AVG Volume (30 Days)
- PMCB 27.8K
- ABVC 1.3M
- Earning Date
- PMCB 03-17-2025
- ABVC 03-21-2025
- Dividend Yield
- PMCB N/A
- ABVC N/A
- EPS Growth
- PMCB N/A
- ABVC N/A
- EPS
- PMCB 0.74
- ABVC N/A
- Revenue
- PMCB N/A
- ABVC $509,788.00
- Revenue This Year
- PMCB N/A
- ABVC N/A
- Revenue Next Year
- PMCB N/A
- ABVC N/A
- P/E Ratio
- PMCB $2.40
- ABVC N/A
- Revenue Growth
- PMCB N/A
- ABVC N/A
- 52 Week Low
- PMCB $1.39
- ABVC $0.40
- 52 Week High
- PMCB $2.58
- ABVC $1.73
- Technical
- Relative Strength Index (RSI)
- PMCB 56.75
- ABVC 53.89
- Support Level
- PMCB $1.57
- ABVC $0.67
- Resistance Level
- PMCB $1.80
- ABVC $0.84
- Average True Range (ATR)
- PMCB 0.13
- ABVC 0.10
- MACD
- PMCB 0.01
- ABVC -0.00
- Stochastic Oscillator
- PMCB 64.10
- ABVC 42.52
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.